Compare RIO & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RIO | CI |
|---|---|---|
| Founded | 1873 | 1792 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3B | 74.6B |
| IPO Year | N/A | N/A |
| Metric | RIO | CI |
|---|---|---|
| Price | $84.89 | $279.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | $85.00 | ★ $353.59 |
| AVG Volume (30 Days) | ★ 2.8M | 1.5M |
| Earning Date | 02-18-2026 | 01-29-2026 |
| Dividend Yield | ★ 4.35% | 2.12% |
| EPS Growth | N/A | ★ 114.09 |
| EPS | 6.28 | ★ 22.63 |
| Revenue | $53,729,000,000.00 | ★ $268,077,000,000.00 |
| Revenue This Year | $7.31 | $12.85 |
| Revenue Next Year | $3.52 | $4.62 |
| P/E Ratio | $14.07 | ★ $12.58 |
| Revenue Growth | N/A | ★ 15.26 |
| 52 Week Low | $51.67 | $239.51 |
| 52 Week High | $85.46 | $350.00 |
| Indicator | RIO | CI |
|---|---|---|
| Relative Strength Index (RSI) | 75.71 | 54.52 |
| Support Level | $79.93 | $274.00 |
| Resistance Level | $85.46 | $289.03 |
| Average True Range (ATR) | 0.99 | 4.90 |
| MACD | 0.34 | 1.03 |
| Stochastic Oscillator | 90.75 | 52.64 |
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.